Winship names Jones and Patel as K12 scholars

The Winship K12 Clinical Oncology Training Program has announced that Drs. Jade Jones and Sagar Patel are this year's K12 scholars. With a grant from the National Cancer Institute, the goal of the Winship K12 program is to develop the next generation of researchers and leaders in clinical oncology. During the two-year mentored training program, each Winship K12 scholar designs an investigator-initiated clinical trial and submits an extramural grant proposal to support it.

About the Winship K12 Program

Routine screenings key to timely cancer diagnosis and care

In the June issue of Georgia Trend magazine, Jennifer Christie, MD, discusses the pandemic's impact on colorectal cancer screening and how it may affect early diagnosis and timely treatment for patients.

Update to Emory COVID-19 protocols

Beginning July 1, any faculty or staff member who is not fully vaccinated will be required to conduct weekly COVID-19 testing. To prepare for this policy change, faculty and staff members will need to share their vaccination status with Emory by July 1.

Call for speakers: BMT Cell Therapy Winter Workshop

Co-chaired by Drs. Marcel van den Brink and Edmund K. Waller, the 10th Annual BMT Cell Therapy Winter Workshop will take place on Dec. 10, before the annual meeting of the American Society of Hematology (ASH). Visit the website to register for free and submit a proposal to present a workshop talk.

Winship Oncology Nursing Symposium this Saturday

The 12th annual Winship Oncology Nursing Symposium, “Getting our Groove Back: Bringing Oncology Nursing to the Forefront,” will be held virtually on June 12. Registration is free for Emory employees. Up to 20 continuing education credits can be earned live or on-demand after the conference.

Webinar: Accelerating immune medicine with proteomics

Join the Emory Integrated Proteomics Core for a webinar on June 15 to learn more about the IsoPlexis product suite and how functional phenotyping is helping unlock the next stage of personalized cancer immunotherapies and vaccines.

Emory and Synthego CRISPR genome editing cell lines

The Emory Integrated Genomics Core, in partnership with Synthego, is offering newly reduced CRISPR editing rates for CRISPR immortalized cell lines (IMM) and induced pluripotent stem cell (iPSC) lines. For more information, contact EIGC@emory.edu.

Learn More

Below are four selected Winship publications out of 108 published over the past week:

Hu X, Chehal PK, Kaplan C, Krukowski RA, Lan RH, Stepanski E, Schwartzberg L, Vidal G, Graetz I. Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy. JAMA Network Open. 2021; 4(6):e2112076. PubMed PMID: 34061200.

View in PubMed

Gilleland Marchak J, Devine KA, Hudson MM, Jacobson LA, Michel G, Peterson SR, Schulte F, Wakefield CE, Sands SA. Systematic Review of Educational Supports of Pediatric Cancer Survivors: Current Approaches and Future Directions. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2021; 39(16):1813-1823. PubMed PMID: 33886350.

View in PubMed

San-Miguel J, Usmani SZ, Mateos MV, van de Donk NWCJ, Kaufman JL, Moreau P, Oriol A, Plesner T, Benboubker L, Liu K, Hellemans P, Masterson T, Clemens PL, Luo M, Farnsworth A, Nahi H, Chari A. Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: Part 2 of the open-label, multicenter, dose-escalation phase 1b study (PAVO). Haematologica. 2021; 106(6):1725-1732. PubMed PMID: 32354874.

View in PubMed

Howard DH, Quek RGW, Fox KM, Arondekar B, Filson CP. The value of new drugs for advanced prostate cancer. Cancer. 2021; PubMed PMID: 34062620.

View in PubMed